Literature DB >> 33443114

Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs.

Anna S Berghoff1,2,3, Yunxiang Liao1,2, Matthia A Karreman1,2, Ayseguel Ilhan-Mutlu3, Katharina Gunkel1,2, Martin R Sprick4, Christian Eisen4, Tobias Kessler1,2, Matthias Osswald1,2, Susanne Wünsche1,2, Manuel Feinauer1,2, Brunhilde Gril5, Frederic Marmé6, Laura L Michel6, Zuszanna Bago-Horvath7, Felix Sahm8,9, Natalia Becker10, Michael O Breckwoldt11, Gergely Solecki1,2, Miriam Gömmel1,2, Lulu Huang1,2, Petra Rübmann2, Carina M Thome2, Miriam Ratliff1,2, Andreas Trumpp4, Patricia S Steeg5, Matthias Preusser3, Wolfgang Wick1,2, Frank Winkler12,2.   

Abstract

Specific biological properties of those circulating cancer cells that are the origin of brain metastases (BM) are not well understood. Here, single circulating breast cancer cells were fate-tracked during all steps of the brain metastatic cascade in mice after intracardial injection over weeks. A novel in vivo two-photon microscopy methodology was developed that allowed to determine the specific cellular and molecular features of breast cancer cells that homed in the brain, extravasated, and successfully established a brain macrometastasis. Those BM-initiating breast cancer cells (BMIC) were mainly originating from a slow-cycling subpopulation that included only 16% to 20% of all circulating cancer cells. BMICs showed enrichment of various markers of cellular stemness. As a proof of principle for the principal usefulness of this approach, expression profiling of BMICs versus non-BMICs was performed, which revealed upregulation of NDRG1 in the slow-cycling BMIC subpopulation in one BM model. Here, BM development was completely suppressed when NDRG1 expression was downregulated. In accordance, in primary human breast cancer, NDRG1 expression was heterogeneous, and high NDRG1 expression was associated with shorter metastasis-free survival. In conclusion, our data identify temporary slow-cycling breast cancer cells as the dominant source of brain and other metastases and demonstrates that this can lead to better understanding of BMIC-relevant pathways, including potential new approaches to prevent BM in patients. IMPLICATIONS: Cancer cells responsible for successful brain metastasis outgrowth are slow cycling and harbor stemness features. The molecular characteristics of these metastasis-initiating cells can be studied using intravital microscopy technology. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 33443114      PMCID: PMC9281611          DOI: 10.1158/1541-7786.MCR-20-0863

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  43 in total

1.  Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.

Authors:  Maria Aparecida Nagai; Renê Gerhard; José Humberto T G Fregnani; Suely Nonogaki; Regina Barbosa Rierger; Mário Mourão Netto; Fernando A Soares
Journal:  Breast Cancer Res Treat       Date:  2010-04-06       Impact factor: 4.872

2.  A cancer stem cell model for studying brain metastases from primary lung cancer.

Authors:  Sara M Nolte; Chitra Venugopal; Nicole McFarlane; Olena Morozova; Robin M Hallett; Erin O'Farrell; Branavan Manoranjan; Naresh K Murty; Paula Klurfan; Edward Kachur; John P Provias; Forough Farrokhyar; John A Hassell; Marco Marra; Sheila K Singh
Journal:  J Natl Cancer Inst       Date:  2013-02-15       Impact factor: 13.506

3.  Real-time imaging reveals the single steps of brain metastasis formation.

Authors:  Yvonne Kienast; Louisa von Baumgarten; Martin Fuhrmann; Wolfgang E F Klinkert; Roland Goldbrunner; Jochen Herms; Frank Winkler
Journal:  Nat Med       Date:  2009-12-20       Impact factor: 53.440

4.  Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.

Authors:  Ding Ren; Xiaoping Zhu; Ren Kong; Zhen Zhao; Jianting Sheng; Jiang Wang; Xiaoyun Xu; Jiyong Liu; Kemi Cui; Xiang H-F Zhang; Hong Zhao; Stephen T C Wong
Journal:  Cancer Res       Date:  2018-03-22       Impact factor: 12.701

5.  Endothelial Notch1 Activity Facilitates Metastasis.

Authors:  Elfriede Wieland; Juan Rodriguez-Vita; Sven S Liebler; Carolin Mogler; Iris Moll; Stefanie E Herberich; Elisa Espinet; Esther Herpel; Amitai Menuchin; Jenny Chang-Claude; Michael Hoffmeister; Christoffer Gebhardt; Hermann Brenner; Andreas Trumpp; Christian W Siebel; Markus Hecker; Jochen Utikal; David Sprinzak; Andreas Fischer
Journal:  Cancer Cell       Date:  2017-02-23       Impact factor: 31.743

Review 6.  The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications.

Authors:  Veerle Melotte; Xianghu Qu; Maté Ongenaert; Wim van Criekinge; Adriaan P de Bruïne; H Scott Baldwin; Manon van Engeland
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

7.  Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance.

Authors:  Nathan Moore; Stephen Lyle
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

8.  The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets.

Authors:  Zaklina Kovacevic; Dong Fu; Des R Richardson
Journal:  Biochim Biophys Acta       Date:  2008-06-26

9.  Molecular characterization of breast cancer CTCs associated with brain metastasis.

Authors:  Debasish Boral; Monika Vishnoi; Haowen N Liu; Wei Yin; Marc L Sprouse; Antonio Scamardo; David S Hong; Tuan Z Tan; Jean P Thiery; Jenny C Chang; Dario Marchetti
Journal:  Nat Commun       Date:  2017-08-04       Impact factor: 14.919

10.  Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

Authors:  Anna S Berghoff; Sophie Schur; Lisa M Füreder; Brigitte Gatterbauer; Karin Dieckmann; Georg Widhalm; Johannes Hainfellner; Christoph C Zielinski; Peter Birner; Rupert Bartsch; Matthias Preusser
Journal:  ESMO Open       Date:  2016-03-16
View more
  9 in total

1.  IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases.

Authors:  R Alejandro Márquez-Ortiz; Maria J Contreras-Zárate; Vesna Tesic; Karen L F Alvarez-Eraso; Gina Kwak; Zachary Littrell; James C Costello; Varsha Sreekanth; D Ryan Ormond; Sana D Karam; Peter Kabos; Diana M Cittelly
Journal:  Clin Cancer Res       Date:  2021-09-20       Impact factor: 12.531

Review 2.  Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.

Authors:  Ryan C Gimple; Kailin Yang; Matthew E Halbert; Sameer Agnihotri; Jeremy N Rich
Journal:  Nat Rev Cancer       Date:  2022-06-16       Impact factor: 69.800

3.  NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.

Authors:  Emilly S Villodre; Xiaoding Hu; Bedrich L Eckhardt; Richard Larson; Lei Huo; Ester C Yoon; Yun Gong; Juhee Song; Shuying Liu; Naoto T Ueno; Savitri Krishnamurthy; Stefan Pusch; Debu Tripathy; Wendy A Woodward; Bisrat G Debeb
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 11.816

4.  Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome.

Authors:  Anna Michel; Thiemo Dinger; Marvin Darkwah Oppong; Laurèl Rauschenbach; Cornelius Deuschl; Yahya Ahmadipour; Daniela Pierscianek; Karsten Wrede; Jörg Hense; Christoph Pöttgen; Antonella Iannaccone; Rainer Kimmig; Ulrich Sure; Ramazan Jabbarli
Journal:  Acta Neurochir (Wien)       Date:  2021-10-22       Impact factor: 2.216

5.  Animal models of brain metastasis.

Authors:  Lauritz Miarka; Manuel Valiente
Journal:  Neurooncol Adv       Date:  2021-11-27

Review 6.  Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.

Authors:  Priyakshi Kalita-de Croft; Vaibhavi Joshi; Jodi M Saunus; Sunil R Lakhani
Journal:  Diseases       Date:  2022-02-03

Review 7.  Liquid biopsies to occult brain metastasis.

Authors:  Asad Ur Rehman; Parvez Khan; Shailendra Kumar Maurya; Jawed A Siddiqui; Juan A Santamaria-Barria; Surinder K Batra; Mohd Wasim Nasser
Journal:  Mol Cancer       Date:  2022-05-10       Impact factor: 41.444

8.  Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model.

Authors:  Jessica Kalra; Jennifer Baker; Justin Song; Alastair Kyle; Andrew Minchinton; Marcel Bally
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

9.  Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases.

Authors:  Anna Michel; Marvin Darkwah Oppong; Laurèl Rauschenbach; Thiemo Florin Dinger; Lennart Barthel; Daniela Pierscianek; Karsten H Wrede; Jörg Hense; Christoph Pöttgen; Andreas Junker; Teresa Schmidt; Antonella Iannaccone; Rainer Kimmig; Ulrich Sure; Ramazan Jabbarli
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.